Optimal Use of Fluoroquinolones in the Intensive Care Unit Setting

John C. Rotschafer, Mary A. Ullman, Christopher J. Sullivan

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Fluoroquinolones have become a staple antimicrobial in a variety of settings for a wide spectrum of infectious diseases. Although fluoroquinolones have been associated with a broad spectrum of adverse events, the side effect profile is generally acceptable. Their use in the intensive care unit as empiric therapy is becoming compromised due to the development of multiple drug resistant gram negative pathogens and collateral damage with C difficile & MRSA. Fluoroquinolones should be used along with another antibiotic of different chemical structure, mechanism of action, and pharmacodynamic profile to ensure adequate initial antimicrobial coverage and maximize the likelihood of a favorable clinical and microbiologic response.

Original languageEnglish (US)
Pages (from-to)95-106
Number of pages12
JournalCritical Care Clinics
Issue number1
StatePublished - Jan 1 2011


  • Fluoroquinolone antibiotics
  • Intensive care unit
  • Pharmacodynamics

Fingerprint Dive into the research topics of 'Optimal Use of Fluoroquinolones in the Intensive Care Unit Setting'. Together they form a unique fingerprint.

Cite this